Table 3.
Trait | Test | β | SE | P value | n |
---|---|---|---|---|---|
WBC | Autosomal | 0.0180 | 0.00281 | 1.46 × 10−10 | 49,353 |
WBC | Autosomal, high CF Yes–Noa | 0.0266 | 0.00373 | 1.10 × 10−12 | 49,353 |
NEU | ChrX | −0.0215 | 0.00458 | 2.74 × 10−6 | 18,415 |
NEU | ChrX, adjusted for Duffy | −0.0155 | 0.00442 | 4.47 × 10−4 | 18,415 |
NEU% | ChrX | −0.0246 | 0.00314 | 5.12 × 10−15 | 16,248 |
NEU% | ChrX, adjusted for Duffy | −0.0242 | 0.00300 | 8.87 × 10−16 | 16,248 |
LYM | Autosomal | 0.0246 | 0.00467 | 1.41 × 10−7 | 33,927 |
LYM | ChrX | 0.0301 | 0.00371 | 5.81 × 10−16 | 19,658 |
LYM | Autosomal, high CF Yes–Noa | 0.0359 | 0.00638 | 1.77 × 10−8 | 33,927 |
LYM% | ChrX | 0.0222 | 0.00243 | 8.11 × 10−20 | 17,245 |
aHigh CF mCA was defined as having estimated CF ≥0.03.
CF, clonal fraction; LYM, lymphocytes; NEU, neutrophils; SE, standard error; WBC, white blood cell counts.